Diabetesa kontrolatzeko eta kontrolatzeko teknologia

BLOOD GLUCOSE MEASUREMENT DEVICE AND METHOD FOR MANAGING BLOOD GLUCOSE MEASUREMENT DATA USING THE SAME

Resumen de: EP4541266A1

A blood glucose measurement device according to an embodiment of the present invention comprises: a measurement unit that is partially inserted into the body of a subject and generates a blood glucose measurement signal by measuring a blood glucose concentration of the subject; a control unit that generates blood glucose measurement data by converting the blood glucose measurement signal into digital data; a storage unit that includes a plurality of storage areas and stores the blood glucose measurement data in the plurality of storage areas; and a communication unit that transmits the blood glucose measurement data stored in at least one of the plurality of storage areas to an external device, wherein the control unit determines the validity of the blood glucose measurement data stored in the plurality of storage areas, and controls the communication unit to transmit the blood glucose measurement data stored in at least one of the plurality of storage areas to the external device, based on a result of the determination.

BLOOD GLUCOSE MEASUREMENT DEVICE AND METHOD FOR MANAGING BLOOD GLUCOSE MEASUREMENT DATA USING THE SAME

Resumen de: EP4541265A1

A blood glucose measurement device according to an embodiment of the present invention comprises: a measurement unit that is partially inserted into the body of a subject and generates a blood glucose measurement signal by measuring a blood glucose concentration of the subject; a control unit that generates blood glucose measurement data by converting the blood glucose measurement signal into digital data; and a storage unit that stores the blood glucose measurement data, wherein the control unit stores the preset first verification data in the storage unit, and stores the blood glucose measurement data in the storage unit continuously to the first verification data.

AUTOMATED MEDICAMENT DELIVERY SYSTEM ADJUSTMENTS WHEN TAKING A PHARMACEUTICAL

Resumen de: EP4542560A1

Disclosed are methods, techniques, systems, and devices that are operable to compensate for the effects of pharmaceuticals on a user's analyte measurement values, such as glucose levels and/or ketone levels. The disclosed system is configured to enable medicament delivery application to enter a pharmaceutical mode. While in pharmaceutical mode, the medicament delivery application is operable to adjust medicament delivery constraints and other settings used by the medicament delivery application to respond to the effects of the pharmaceutical on the user's analyte measurement values.

SYSTEMS AND METHODS FOR PROCESSING AND TRANSMITTING SENSOR DATA

Resumen de: EP4542574A2

Systems and methods for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor, are disclosed. In an embodiment, a method for transmitting data between a first communication device associated with an analyte sensor and a second communication device configured to provide user access to sensor-related information comprises: activating a transceiver of a first communication device associated with an analyte sensor at a first time; and establishing a two-way communication channel with the second communication device; wherein the activating comprises waking the transceiver from a low power sleep mode using a forced wakeup from the second communication device.

AUTOMATIC DRUG DELIVERY SYSTEM FOR DELIVERY OF A GLP-1 THERAPEUTIC

Resumen de: EP4541390A2

The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal dosing of GLP-1 or co-formulation of GLP-1 and insulin. The size and frequency of the basal doses may be controlled by a medication delivery algorithm resident on the wearable drug delivery device based on a basal dosing history and readings from a continuous glucose monitor monitoring the glucose levels of the wearer of the device.

NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICE WITH WEARING FIT DETECTION FUNCTION

Resumen de: EP4541276A1

The invention provides a non-invasive blood glucose monitoring device with a wearing fit detection function, comprising a substrate, a blood glucose monitoring module, an optical feedback sensing module and at least one light-blocking wall. The substrate defines a first setting area for disposing the blood glucose monitoring module and a second setting area for disposing the optical feedback sensing module. The second setting area is between an edge of the substrate and the first setting area. The optical feedback sensing module includes at least one light-emitting element and at least one light-receiving element. Each light-emitting element emits a light signal corresponding to at least one specific wavelength, and each light-receiving element receives the light signal corresponding to the at least one specific wavelength, after being reflected, as a basis for determining the wearing fit. The at least one light-blocking wall is located between the first setting area and the second setting area.

SYSTEMS, DEVICES, AND METHODS RELATING TO MEDICATION DOSE GUIDANCE

Resumen de: AU2023379646A1

Systems, devices and methods are provided for titration of a medication dose for a patient or user. The titration may be based on determining a hypoglycemic risk of a user for a plurality of time-of-day periods. The determination of the hypoglycemic risk may be accomplished by known methods, including the glucose pattern analysis, glucose dysregulation analysis, low alarm frequency analysis, and combinations thereof. The system may then select a recommended action based on the analyte pattern type. The system may then store an indicator of the recommended action in a computer memory for output. The system may then output the recommended action. The recommended action may be outputted to the user, an HCP, or a caregiver. The recommended action may also vary depending on who is receiving the recommended action.

Wearable micro-dosing drug delivery device

Resumen de: AU2025202313A1

The disclosed embodiments are directed to a wearable automatic drug delivery device configured to provide basal-only dosing of insulin. In a primary embodiment, the wearable drug delivery device is configured to provide automatic operation and provides audible alerts and visual status indicators to the patient. In other embodiments, the patient may have some degree of control over the operation of the device by providing tapping gestures on housing of the device. In yet another embodiment, the patient may provide input and receive status from the device via an application executing on a portable computing device in wireless communication with the wearable drug delivery device.

INSULIN PUMP AND PORTABLE BATTERY PACK SET

Resumen de: WO2025079745A1

The present invention provides a novel method for providing power to an insulin pump in order to facilitate the full return of a diabetic patient to normal daily life. The present invention includes: an insulin pump that is connected inside the body and administers insulin; and a portable battery pack that can provide power to the insulin pump by coming into contact with one side of the insulin pump. The insulin pump comprises: an injection unit for injecting insulin into the body: a first battery unit that stores power for operating the insulin pump and can be repeatedly charged and discharged; an operation unit, provided on a portion of one surface of the insulin pump, for operating the insulin pump; a first charging unit provided on a portion of the one surface of the insulin pump and connected to the first battery unit in contact with the portable battery pack in order to provide power; and a control unit for controlling the injection unit, the first battery unit, and the operation unit. The portable battery pack comprises: a second battery unit that can charge the first battery unit by using the stored power; and a second charging unit that comes into contact with the first charging unit in order to charge the first battery unit.

METHOD AND SYSTEM FOR GLYCEMIC PREDICTION AND DYNAMIC VISUALIZATION

Resumen de: WO2025081104A1

Disclosed herein are system, method, and computer program product embodiments for analyzing the impact of personal choices on future glucose levels. The disclosed techniques assess the consequences of decisions involving diet and exercise on future glucose levels using trained models and display personally relatable, intuitive, and modifiable visualizations of predicted future glucose levels. The disclosed interface allows the user to adjust the sequencing of these decisions and portion sizes of meal choices and immediately visualize the impact on predicted future glucose levels. The interface seamlessly integrates with partner systems and with wearable fitness devices.

HEALTH TRACKING DEVICE

Resumen de: US2025125031A1

A device may receive, from a plurality of sensors, sensor data relating to a user. The device may include a plurality of types of sensors including a spectrometer and one or more of an accelerometer, a heart rate sensor, a blood pressure sensor, a blood sugar sensor, a perspiration sensor, a skin conductivity sensor, or an imaging sensor. The device may process the sensor data, from the plurality of types of sensors, relating to the user to determine a health condition of the user. The device may provide, via a user interface, information identifying the health condition of the user based on processing the sensor data, from the plurality of types of sensors, relating to the user.

INSULIN INFUSION SET

Resumen de: US2025121133A1

Embodiments of devices and methods to maintain preservative concentration in a medication delivered using a medical device are provided. A barrier layer can be used to prevent migration of preservatives. A vent can be used to allow release of preservatives prior to delivery to the patient. An absorbent element can be used to maintain preservative concentration at a desired level. A filter can be used to capture particulates from the medication prior to delivery to a patient.

NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICE AND MANUFACTURING METHOD THEREOF

Resumen de: US2025120617A1

The invention provides a manufacturing method for a non-invasive blood glucose monitoring device, which comprises the following steps: providing a substrate; performing an injection molding process or an electroplating process, to form at least one light-blocking wall on the substrate, wherein each light-blocking wall includes a lower wall-structure and an upper wall-structure, and the lower wall-structure connects the substrate and the upper wall-structure connects the lower wall-structure; arranging a light-emitting element and a light-receiving element on the substrate and separating the light-emitting element and the light-receiving element by the at least one light-blocking wall; forming a packaging structure on the substrate in which the light-emitting element and the light-receiving element are packaged; and disposing a transparent cover on the packaging structure and the at least one light-blocking wall and limiting the transparent cover to a configuration height by the at least one light-blocking wall.

NON-INVASIVE BLOOD GLUCOSE MONITORING MODULE WITH HIGH OPTICAL TRANSMITTANCE

Resumen de: US2025120618A1

A non-invasive blood glucose monitoring module with high optical transmittance includes a substrate, a first detecting unit and a second detecting unit. The first detecting unit includes a first light source set, a first photosensitive element and first blocking wall structures. The first photosensitive element receives light, with a first wavelength, emitted from the first light source set. The first blocking wall structures are located between the two first light-emitting elements and between the first light source set and the first photosensitive element. The second detecting unit includes a second light source set, a second photosensitive element and second blocking wall structures. The second photosensitive element receives light, with a second wavelength, emitted from the second light source set. The second blocking wall structures are located between the two second light-emitting elements and between the second light source set and the second photosensitive element.

METHOD AND SYSTEM FOR GLYCEMIC PREDICTION AND DYNAMIC VISUALIZATION

Resumen de: US2025120619A1

Disclosed herein are system, method, and computer program product embodiments for interconnecting a prediction visualization with user medical data for analyzing the impact of personal choices on future glucose levels. The prediction visualization is configured to generate predictions of glycemic impact based one or more inputs including choices involving diet and exercise and user medical data, such as the user's historical and current glucose levels. The prediction visualization is configured to be adjustable based on user input and the visualization is configured to dynamically update based on user input. The disclosed interface allows the user to adjust the sequencing of these decisions and portion sizes of meal choices and immediately generate new visualizations representing the impact on predicted future glucose levels.

LASER-INDUCED GRAPHENE NON-ENZYMATIC GLUCOSE SENSORS FOR ON BODY MEASUREMENTS

Resumen de: US2025120616A1

Embodiments relate to a non-enzymatic glucose sensor. The non-enzymatic glucose sensor comprises one or more electrodes, a microfluidic channel, and at least one inlet, wherein the at least one inlet is configured to deliver a fluid to a microfluidic channel and wherein the microfluidic channel is configured to transport the fluid to the one or more electrodes. At least one of the one or more electrodes is a laser-induced graphene electrode, wherein the laser-induced graphene electrode comprises one or more uniform coatings of metal.

METHOD FOR SEARCHING FOR LOST DEVICE, APPLIED TO DIABETES MANAGEMENT SYSTEM

Resumen de: WO2025076766A1

A method for searching for a lost device, applied to a diabetes management system. The diabetes management system comprises at least one wearable medical device, at least one personal management device and one secondary management device, wherein at least one of the personal management device and the secondary management device can be used to control the wearable medical device, and the personal management device is in communication connection with the secondary management device; and when one of the personal management device and the secondary management device is identified as lost, the lost device is searched for by means of the other one of the personal management device and the secondary management device, such that a user can easily find the lost device.

DEVICES AND TECHNIQUES FOR ULTRASOUND THERAPY VIA A DIALYSIS SYSTEM

Resumen de: US2025121213A1

A dialysis-ultrasound system is described that includes an ultrasound therapy device integrated with a catheter to incorporate ultrasound therapy into a dialysis system. The ultrasound device may be or may include a high-intensity focused ultrasound (HIFU) device or peripheral focused ultrasound stimulation (pFUS) device. The ultrasound therapy may target the liver, for example, to treat diabetes. In one example, a system includes a catheter configured to be arranged within the peritoneal cavity of a patient for peritoneal dialysis (PD), and an ultrasound device configured to emit ultrasound waves. The ultrasound device is integrated with the catheter and is arranged on the catheter to be implanted within the peritoneal cavity of the patient to provide ultrasound therapy to a target region of the patient. Other embodiments are described.

INSULIN NEEDLE TIP PROTECTION MECHANISM AND INSULIN INJECTION DEVICE

Resumen de: WO2025076843A1

An insulin needle tip protection mechanism and an insulin injection device. According to the insulin needle tip protection mechanism, by means of the cooperation of a U-shaped reciprocating groove (3) and an elastic wall (6), a needle tip can be automatically retracted after injection, and cannot be pushed out again, so that the purpose of needle tip protection is achieved, and secondary use can also be avoided.

INSULIN SYRINGE REPLACEMENT SYSTEM FOR INSULIN PUMP

Resumen de: WO2025079746A1

The present invention relates to an insulin pump, which is a medical device for diabetic patients, and to a system for providing a safety device for preventing an accident that may occur when an insulin syringe for supplying insulin to the insulin pump is replaced. An insulin syringe replacement system for an insulin pump provided by the present invention comprises: a control unit for controlling the operation of the insulin pump; an operation unit for performing an initialization setting operation when an insulin syringe is replaced under the control of the control unit; and a battery unit for supplying power to the control unit and the operation unit; a housing unit for mounting the insulin syringe; and a sensor unit for confirming whether a stopper of the insulin syringe mounted on the housing unit is coupled and notifying the control unit of the confirmation, wherein the control unit controls the operation unit to perform the initialization setting operation only after receiving the confirmation from the sensor unit that the stopper of the insulin syringe mounted on the housing unit is coupled.

Method and sensor

Resumen de: GB2634673A

A sensor 100 for extracting and detecting an analyte (e.g. glucose, hormones, toxins, biomarkers) from a subject comprises at least one co-monitoring sensor pixel 110, a substrate 102 for positioning on the subject’s skin 200, and a set of electrodes 112. The substrate has at least one reservoir 108. The set of electrodes includes extraction electrodes for iontophoretic extraction of the analyte and a reference substance into the reservoir, target detection electrodes for detecting the amount of analyte in the reservoir, and reference detection electrodes for detecting the amount of reference substance in the reservoirs. Analyte concentration may be estimated by receiving a signal corresponding to the amount of analyte extracted into the sensor reservoir through a set of dermal channels 204 (e.g. hair follicles or microneedles), and determining the number of dermal channels in the set. Analyte flux through a selected number of dermal channels is determined based on the signal and dermal channel number . A reference flux of the reference substance through the selected number of dermal channels at a reference concentration is obtained (e.g. from a look-up table), and analyte concentration estimated based on analyte flux, reference flux and reference concentration.

NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICE AND MANUFACTURING METHOD THEREOF

Resumen de: EP4537752A1

The invention provides a manufacturing method for a non-invasive blood glucose monitoring device, which comprises the following steps: providing a substrate; performing an injection molding process or an electroplating process, to form at least one light-blocking wall on the substrate, wherein each light-blocking wall includes a lower wall-structure and an upper wall-structure, and the lower wall-structure connects the substrate and the upper wall-structure connects the lower wall-structure; arranging a light-emitting element and a light-receiving element on the substrate and separating the light-emitting element and the light-receiving element by the at least one light-blocking wall; forming a packaging structure on the substrate in which the light-emitting element and the light-receiving element are packaged; and disposing a transparent cover on the packaging structure and the at least one light-blocking wall and limiting the transparent cover to a configuration height by the at least one light-blocking wall.

BLOOD SUGAR MEASUREMENT DEVICE AND METHOD

Resumen de: EP4537751A1

A blood glucose measurement device having a display, includes a housing having one or more openings on one side, one or more contact electrodes configured to electrically coupled to a sensor strip inserted into the housing through the one or more openings, one or more control buttons configured to turn on the blood glucose measurement device, and one or more processors configured to control a first execution screen to be displayed in response to receiving a first signal by the one or more contact electrodes and, display a second execution screen in response to receiving a second signal by the one or more control buttons.

SYSTEM AND METHOD TO FORM CONTINUOUS GLUCOSE MONITORING DEVICE

Resumen de: WO2025074375A1

Disclosed herein is a system (100) and method (500) to form a continuous glucose monitoring (CGM) device The system (100) includes a modular housing (106) that has a display unit (102). The system (100) further includes a continuous glucose monitoring (CGM) patch (112) that is removably disposed within the modular housing (106) and communicably coupled to the display unit (102). The CGM patch (112) detects a glucose content of a user. The display unit (102) outputs the detected glucose content of the user for a first period. Based on a completion of the first period, the CGM patch (112) is removed from the modular housing (106).

BIOSIGNAL MEASUREMENT ELECTRODE AND METHOD FOR PRODUCING SAME

Nº publicación: US2025114023A1 10/04/2025

Solicitante:

RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIV [KR]
Research & Business Foundation Sungkyunkwan University